Literature DB >> 8163637

Melanoma, immune surveillance, and immunotherapy.

S Ferrone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8163637      PMCID： PMC294144          DOI： 10.1172/JCI117108

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  7 in total

1.  Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

Authors:  S A Rosenberg; B S Packard; P M Aebersold; D Solomon; S L Topalian; S T Toy; P Simon; M T Lotze; J C Yang; C A Seipp
Journal:  N Engl J Med       Date:  1988-12-22       Impact factor: 91.245

2.  Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.

Authors:  T Kageshita; Z Wang; L Calorini; A Yoshii; T Kimura; T Ono; S Gattoni-Celli; S Ferrone
Journal:  Cancer Res       Date:  1993-07-15       Impact factor: 12.701

3.  Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

Authors:  P O Livingston; E J Natoli; M J Calves; E Stockert; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 4.  T cell responses to human malignant tumours.

Authors:  A Knuth; T Wölfel; K H Meyer zum Büschenfelde
Journal:  Cancer Surv       Date:  1992

5.  Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.

Authors:  A Mittelman; Z J Chen; H Yang; G Y Wong; S Ferrone
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

Review 6.  MHC antigens in human melanomas.

Authors:  D J Ruiter; V Mattijssen; E B Broecker; S Ferrone
Journal:  Semin Cancer Biol       Date:  1991-02       Impact factor: 15.707

7.  Identification of human cancers deficient in antigen processing.

Authors:  N P Restifo; F Esquivel; Y Kawakami; J W Yewdell; J J Mulé; S A Rosenberg; J R Bennink
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307
  7 in total
  2 in total

1.  The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice.

Authors:  U Mrowietz; U Schwenk; S Maune; J Bartels; M Küpper; I Fichtner; J M Schröder; D Schadendorf
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

2.  Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.

Authors:  P Möller; Y Sun; T Dorbic; S Alijagic; A Makki; K Jurgovsky; M Schroff; B M Henz; B Wittig; D Schadendorf
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.